News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
India’s Sun Pharmaceutical Industries Ltd Gets US Nod to Sell Cancer Drug
September 23, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW DELHI, Sept 23 (Reuters) - India's Sun Pharmaceutical Industries said on Tuesday it had approval from the U.S. Food and Drug Administration to market generic versions of Paraplatin, which is indicated for the treatment of ovarian cancer.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
MORE ON THIS TOPIC
FDA
FDA’s Hoeg Reportedly Trying To Hire Friend, Fellow Antidepressant Skeptic
March 5, 2026
·
2 min read
·
Tristan Manalac
Regulatory
PepGen’s Mid-Stage Myotonic Dystrophy Study Hit With ‘Surprise’ Pause
March 5, 2026
·
2 min read
·
Tristan Manalac
Collaboration
Roche Broadens Global Clinical Trial Footprint With $480M+ South Korea Pledge
March 5, 2026
·
1 min read
·
Tristan Manalac
Supply chain
FDA Sends 30 Warning Letters To Continue Clampdown on Compounded GLP-1s
March 4, 2026
·
2 min read
·
Nick Paul Taylor